Company intelligence / Profile preview

Cosmo Pharmaceuticals

Dublin, Irelandcosmopharma.com ↗
Ownership
Public · COPN
Employees
~325
Development stage
Commercial
01

Overview

Cosmo has successfully developed, obtained regulatory approval for, and commercialized several drugs targeting gastrointestinal diseases and dermatology. Its proprietary MMX® technology enables targeted drug delivery in the colon. The company also markets AI-powered medical devices like GI Genius™ to assist clinicians during colonoscopy. Products such as Lialda®, Uceris®, Aemcolo®, Winlevi®, Eleview®, Lumeblue® are approved in major markets. Recent clinical results include positive Phase III data for Methylene Blue MMX®.

Therapeutic areas
GastroenterologyDermatologyOncologyInfectious Diseases
Modalities
Small moleculesMedical devices
Industry
Biotech
02

Drug pipeline

10 assets

budesonide MMX

Approved

9 more assets in the full pipeline.

03

Partnerships

Shire plcBausch HealthFerringSantarusDr. Falk Pharma
04

Financials

Market cap
$29.2M
Total revenue
$65.3M
Enterprise value
$43.3M

Beyond the preview

Go deeper on Cosmo Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cosmo Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call